BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31364487)

  • 1. Cancer Stem Cells in the Development of Novel Therapeutics for Refractory Pediatric Leukemia.
    Brennan L; Narendran A
    Stem Cells Dev; 2019 Oct; 28(19):1277-1287. PubMed ID: 31364487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations for targeting malignant stem cells in leukemia.
    Guzman ML; Jordan CT
    Cancer Control; 2004; 11(2):97-104. PubMed ID: 15024346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
    Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z
    Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
    Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
    Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors.
    Venton G; Pérez-Alea M; Baier C; Fournet G; Quash G; Labiad Y; Martin G; Sanderson F; Poullin P; Suchon P; Farnault L; Nguyen C; Brunet C; Ceylan I; Costello RT
    Blood Cancer J; 2016 Sep; 6(9):e469. PubMed ID: 27611922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of SIRT1 in the growth and regulation of normal hematopoietic and leukemia stem cells.
    Li L; Bhatia R
    Curr Opin Hematol; 2015 Jul; 22(4):324-9. PubMed ID: 26049753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could Vitamin D Analogues Be Used to Target Leukemia Stem Cells?
    García-Ramírez I; Martín-Lorenzo A; González-Herrero I; Rodriguez-Hernández G; Vicente-Dueñas C; Sánchez-García I
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27275819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia.
    Perko R; Kang G; Sunkara A; Leung W; Thomas PG; Dallas MH
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):130-6. PubMed ID: 25445640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia.
    Laing AA; Harrison CJ; Gibson BES; Keeshan K
    Exp Hematol; 2017 Oct; 54():40-50. PubMed ID: 28668350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute leukemia in adults].
    Eigendorff E; Hochhaus A
    Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the bone marrow microenvironment in acute leukemia.
    Karantanou C; Godavarthy PS; Krause DS
    Leuk Lymphoma; 2018 Nov; 59(11):2535-2545. PubMed ID: 29431560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update of ALDH as a Potential Biomarker and Therapeutic Target for AML.
    Yang X; Yao R; Wang H
    Biomed Res Int; 2018; 2018():9192104. PubMed ID: 29516013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-551b is highly expressed in hematopoietic stem cells and a biomarker for relapse and poor prognosis in acute myeloid leukemia.
    de Leeuw DC; Verhagen HJ; Denkers F; Kavelaars FG; Valk PJ; Schuurhuis GJ; Ossenkoppele GJ; Smit L
    Leukemia; 2016 Mar; 30(3):742-6. PubMed ID: 26108690
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel drug targets in acute leukemia.
    Stock W
    Clin Adv Hematol Oncol; 2015 Aug; 13(8):493-5. PubMed ID: 26351809
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation of occult clonogenic leukemia drug sensitivity with relapse after autologous bone marrow transplantation.
    Miller CB; Zehnbauer BA; Piantadosi S; Rowley SD; Jones RJ
    Blood; 1991 Aug; 78(4):1125-31. PubMed ID: 1868244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmembrane TNF-α preferentially expressed by leukemia stem cells and blasts is a potent target for antibody therapy.
    Zhou X; Zhou S; Li B; Li Q; Gao L; Li D; Gong Q; Zhu L; Wang J; Wang N; Huang L; Zhao L; Li Z; Zhou J
    Blood; 2015 Sep; 126(12):1433-42. PubMed ID: 26224647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemia stem cells.
    Buss EC; Ho AD
    Int J Cancer; 2011 Nov; 129(10):2328-36. PubMed ID: 21796620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting LSCs through membrane antigens selectively or preferentially expressed on these cells.
    Pelosi E; Castelli G; Testa U
    Blood Cells Mol Dis; 2015 Dec; 55(4):336-46. PubMed ID: 26460257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and an analysis of prognostic factors.
    Yan CH; Wang JZ; Liu DH; Xu LP; Chen H; Liu KY; Huang XJ
    Eur J Haematol; 2013 Oct; 91(4):304-14. PubMed ID: 23837640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.